Structure Shows That a Glycosaminoglycan and Protein Recognition Site in Factor H Is Perturbed by Age-related Macular Degeneration-linked Single Nucleotide Polymorphism*

A common single nucleotide polymorphism in the factor H gene predisposes to age-related macular degeneration. Factor H blocks the alternative pathway of complement on self-surfaces bearing specific polyanions, including the glycosaminoglycan chains of proteoglycans. Factor H also binds C-reactive protein, potentially contributing to noninflammatory apoptotic processes. The at risk sequence contains His (rather than Tyr) at position 402 (384 in the mature protein), in the seventh of the 20 complement control protein (CCP) modules (CCP7) of factor H. We expressed both His402 and Tyr402 variants of CCP7, CCP7,8, and CCP6-8. We determined structures of His402 and Tyr402 CCP7 and showed them to be nearly identical. The side chains of His/Tyr402 have similar, solvent-exposed orientations far from interfaces with CCP6 and -8. Tyr402 CCP7 bound significantly more tightly than His402 CCP7 to a heparin affinity column as well as to defined-length sulfated heparin oligosaccharides employed in gel mobility shift assays. This observation is consistent with the position of the 402 side chain on the edge of one of two glycosaminoglycan-binding surface patches on CCP7 that we inferred on the basis of chemical shift perturbation studies with a sulfated heparin tetrasaccharide. According to surface plasmon resonance measurements, Tyr402 CCP6-8 binds significantly more tightly than His402 CCP6-8 to immobilized C-reactive protein. The data support a causal link between H402Y and age-related macular degeneration in which variation at position 402 modulates the response of factor H to age-related changes in the glycosaminoglycan composition and apoptotic activity of the macula.

[1]  Don H. Anderson,et al.  Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.

[2]  Marion C. Cohen.  STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM , 2007 .

[3]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration , 2006 .

[4]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[5]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[6]  Victoria A. Higman,et al.  His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form* , 2006, Journal of Biological Chemistry.

[7]  B. Rosner,et al.  CFH Gene Variant, Y402H, and Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration , 2006, Human Heredity.

[8]  P. Zipfel,et al.  Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). , 2006, Kidney International.

[9]  D. Uhrín,et al.  Disease-associated Sequence Variations Congregate in a Polyanion Recognition Patch on Human Factor H Revealed in Three-dimensional Structure* , 2006, Journal of Biological Chemistry.

[10]  J. Nowak,et al.  Age-related macular degeneration (AMD): pathogenesis and therapy. , 2006, Pharmacological reports : PR.

[11]  M. Oppermann,et al.  The C‐terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein , 2006, Clinical and experimental immunology.

[12]  T. Jokiranta,et al.  Localization of the third heparin-binding site in the human complement regulator factor H1. , 2006, Molecular immunology.

[13]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[14]  John D Lambris,et al.  Drusen complement components C3a and C5a promote choroidal neovascularization , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Stefan Heinen,et al.  Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. , 2005, The American journal of pathology.

[16]  J. Provis,et al.  Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration , 2005, Clinical & experimental optometry.

[17]  Jurg Ott,et al.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.

[18]  Wayne Boucher,et al.  The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.

[19]  D. Bok.  Evidence for an inflammatory process in age-related macular degeneration gains new support. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  I. Campbell,et al.  Towards a Structure for a TSG-6·Hyaluronan Complex by Modeling and NMR Spectroscopy , 2005, Journal of Biological Chemistry.

[22]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[23]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[24]  Tai-huang Huang,et al.  Solution structure and heparin interaction of human hepatoma-derived growth factor. , 2004, Journal of molecular biology.

[25]  E. Gherardi,et al.  The Interactions of Hepatocyte Growth Factor/Scatter Factor and Its NK1 and NK2 Variants with Glycosaminoglycans Using a Modified Gel Mobility Shift Assay , 2004, Journal of Biological Chemistry.

[26]  M. Lyon,et al.  A New Model for the Domain Structure of Heparan Sulfate Based on the Novel Specificity of K5 Lyase* , 2004, Journal of Biological Chemistry.

[27]  S. Grzesiek,et al.  Direct observation of Calpha-Halpha...O=C hydrogen bonds in proteins by interresidue h3JCalphaC' scalar couplings. , 2003, Journal of the American Chemical Society.

[28]  Gert Vriend,et al.  Quantitative evaluation of experimental NMR restraints. , 2003, Journal of the American Chemical Society.

[29]  G. Ball,et al.  Solution structure of a functionally active fragment of decay-accelerating factor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Ranganathan,et al.  A common site within factor H SCR 7 responsible for binding heparin, C‐reactive protein and streptococcal M protein , 2003 .

[31]  Dirk Labudde,et al.  A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics , 2002, Journal of biomolecular NMR.

[32]  A. Kungl,et al.  Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. , 2002, Biochemistry.

[33]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[34]  S. Perkins,et al.  Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. , 2001, Journal of molecular biology.

[35]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[36]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[37]  M. Kirkitadze,et al.  Structure and flexibility of the multiple domain proteins that regulate complement activation , 2001, Immunological reviews.

[38]  S. Ranganathan,et al.  Multiple ligand binding sites on domain seven of human complement factor H. , 2001, International immunopharmacology.

[39]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[40]  S. Meri,et al.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b. , 2000, The Journal of biological chemistry.

[41]  M. Pangburn,et al.  Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. , 2000, Immunopharmacology.

[42]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  N. C. Price,et al.  Co‐operativity between modules within a C3b‐binding site of complement receptor type 1 , 1999, FEBS letters.

[44]  S. Meri,et al.  Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. , 1999, Journal of immunology.

[45]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[46]  P. Zipfel,et al.  Identification of the second heparin-binding domain in human complement factor H. , 1998, Journal of immunology.

[47]  T. Nakamura,et al.  Hepatocyte Growth Factor/Scatter Factor Binds with High Affinity to Dermatan Sulfate* , 1998, The Journal of Biological Chemistry.

[48]  M. E. Verdugo,et al.  Age-related increase in activity of specific lysosomal enzymes in the human retinal pigment epithelium. , 1997, Experimental eye research.

[49]  M Nilges,et al.  Ambiguous distance data in the calculation of NMR structures. , 1997, Folding & design.

[50]  D. Lublin,et al.  Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. , 1996, Journal of immunology.

[51]  P. Zipfel,et al.  Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. , 1995, Journal of immunology.

[52]  F. Quiocho.  Probing the atomic interactions between proteins and carbohydrates. , 1993, Biochemical Society transactions.

[53]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[54]  I. Campbell,et al.  Three-dimensional structure of a complement control protein module in solution. , 1991, Journal of molecular biology.

[55]  S. Meri,et al.  Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Robert B Sim,et al.  Purification and structural studies on the complement-system control protein beta 1H (Factor H). , 1982, The Biochemical journal.

[57]  R. Schreiber,et al.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution , 1977, The Journal of experimental medicine.

[58]  B. Morgan,et al.  Complement component C6 deficiency in the Western Cape, South Africa; segregation of four genetic defects , 2007 .

[59]  Michael Nilges,et al.  NOE assignment with ARIA 2.0: the nuts and bolts. , 2004, Methods in molecular biology.

[60]  R. Campbell,et al.  Partial characterization of human complement factor H by protein and cDNA sequencing: Homology with other complement and non-complement proteins , 1986, Bioscience reports.